ADR · ASX

Adherium Ltd. (ASX:ADR)

AU$0.007

 0.0 (0.0%)
ASX:Live
01/05/2025 11:41:53 AM
Near Support Near 52 Week Low HALO Ords GROWTH AUS Big Candle +1
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

ADR Overview

ADR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About ADR

Telephone

N/A

Address

Description

Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies. It operates through the following geographical segments: New Zealand and Australia, South-East Asian Countries, and Other Countries. The firm's Hailie system is transforming management of chronic respiratory conditions, especially asthma and chronic obstructive pulmonary disease. The company was founded by Garth Sutherland in 2001 and is headquartered in Melbourne, Australia.

ADR Price Chart

Key Stats

Market Cap

AU$6.82M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.03

Trade Value (12mth)

US$2,097.00

1 week

-22.22%

1 month

-30%

YTD

-50%

1 year

-65%

All time high

10.31

Key Fundamentals

EPS 3 yr Growth

-88.50%

EBITDA Margin

%

Operating Cashflow

-$11m

Free Cash Flow Return

-134.80%

ROIC

-129.90%

Interest Coverage

-5,802.20

Quick Ratio

2.40

Other Data

Shares on Issue (Fully Dilluted)

758m

HALO Sector

Next Company Report Date

27-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

NZD

Short Sell (% of issue)

0.00

ADR Announcements

Latest Announcements

Date Announcements

30 April 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 April 25

Results of Extraordinary General Meeting

×

Results of Extraordinary General Meeting

07 April 25

Notification of cessation of securities - ADR

×

Notification of cessation of securities - ADR

28 March 25

Notice of Extraordinary General Meeting/Proxy Form

×

Notice of Extraordinary General Meeting/Proxy Form

21 March 25

Board and Executive Leadership Update

×

Board and Executive Leadership Update

19 March 25

Notification regarding unquoted securities - ADR

×

Notification regarding unquoted securities - ADR

18 March 25

Adherium Secures $2.6M to Advance Smart Inhaler in US

×

Adherium Secures $2.6M to Advance Smart Inhaler in US

18 March 25

Investor Presentation

×

Investor Presentation

18 March 25

Proposed issue of securities - ADR

×

Proposed issue of securities - ADR

18 March 25

Proposed issue of securities - ADR

×

Proposed issue of securities - ADR

17 March 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

07 March 25

Management Change - Update

×

Management Change - Update

28 February 25

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

27 February 25

Change in substantial holding

×

Change in substantial holding

31 January 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

09 December 24

Notification regarding unquoted securities - ADR

×

Notification regarding unquoted securities - ADR

05 December 24

Adherium, AMC Health partner for Improved Respiratory Care

×

Adherium, AMC Health partner for Improved Respiratory Care

04 December 24

Partnership with Tenovi for Remote Patient Monitoring

×

Partnership with Tenovi for Remote Patient Monitoring

04 December 24

Adherium Secures R&D Loan Facility

×

Adherium Secures R&D Loan Facility

15 November 24

Results of Meeting

×

Results of Meeting

15 November 24

Amended Constitution

×

Amended Constitution

31 October 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 October 24

Management Change

×

Management Change

09 October 24

Notice of Annual General Meeting/Proxy Form - Replacement

×

Notice of Annual General Meeting/Proxy Form - Replacement

08 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ADR Shortsell

Frequently Asked Questions

The current share price of Adherium Ltd. (ADR:ASX) is AU$0.007.
The 52-week high share price for Adherium Ltd. (ADR:ASX) is AU$0.03.
The 52-week low share price for Adherium Ltd. (ADR:ASX)? is AU$0.01.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) has a franking level of 0.0%.
Adherium Ltd. (ADR:ASX) is classified in the Healthcare.
The current P/E ratio for Adherium Ltd. (ADR:ASX) is .